About Us

Vitro Biopharma provides and continuously improves stem cells and related produducts and services according to applicable regulations.  The discovery of embryonic stem cells capable of differentiation into any cell type of the body was largely responsible for the development of modern stem cell technology.  Embryonic stem cells are also ethically contentious since, in certain cases, embryo destruction results from the use of embryonic stem cells.  However, adult stem cells are derived through non-destructive procedures from a variety of tissue sources.  Adult stem cells have been approved for clinical use for over 50 years and have a strong record of safety and efficacy for use in the treatment of numerous blood disorders and immunological conditions.  Presently, the MSC sector of stem cell research is one of the most rapidly growing and expanding fields within the entire stem cell industry.

Vitro Biopharma News

Vitro Biopharma Company Overview

The US-based Vitro Biopharma is focused on achieving the full potential of regenerative medicine. Established in 1986, Vitro Biopharma provides a unique mix of research and clinical products used by leading universities and institutions worldwide. Over the last 25...

Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative

Golden, Colorado-April 30, 2019-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma one of the world’s emerging biotechnology companies focused on allogeneic Mesenchymal Stem Cell (“MSC”) research and clinical products including AlloRx Stem Cells™,  Brain Grow...

Vitro Biopharma Obtains CLIA Certification

Golden, Colorado—April 2, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of a Certificate of Compliance with CLIA (Clinical Laboratory Improvement Amendment) without deficiencies.  This allows Vitro Biopharma to perform clinical...

Vitro Biopharma 1st Quarter ended January 31st 2019 Financial Results of Operations

Golden, Colorado-March 21, 2018-Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st 2019 financial results of operations.  Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 1st quarter in...

Vitro Biopharma Receives Approval for a Stem Cell Clinical Trial for Musculoskeletal Conditions by the Bahamas Ministry of Health

Golden, Colorado—March 12, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of provisional approval from the National Stem Cell Ethics Committee (NSCEC) of the Ministry of Health of the Commonwealth of the Bahamas for a clinical trial...

Vitro Biopharma:Proven Leaders in Stem Cell-based Regenerative Medicine

Vitro Biopharma: Proven Leaders in Stem Cell-based Regenerative MedicineThe Need for Regenerative TherapiesIt is clear that the current healthcare sector needs a shift towards regenerative therapies to help the correction of underlying diseases by utilizing innate...

Vitro Biopharma 2018 CEO Shareholder Letter

Press Release                                                                                  Source: Vitro Diagnostics, Inc. Vitro Biopharma 2018 CEO Shareholder Letter:Record Revenues from Stem Cell Treatments Lead to 4th Quarter BreakevenCashflow & Growth...

Key Advances in Stem Cell Technology during 2018 Expand Vitro Biopharma Markets

2018 saw accelerated understanding of the roles of stem cells in health and disease.  The Shruti Naik lab at the Rockefeller University Howard Hughes Institute demonstrated close interrelationship between immune cells and stem cells.  Stem cells store memories of...

Vitro Biopharma Receives ISO 9001 Certification of its Quality Management System

Golden, Colorado-December 12th, 2018-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma (“Vitro”) one of the world’s emerging biotechnology companies focused on Umbilical Cord Mesenchymal Stem Cell (“MSC”) research and clinical products has been awarded...

Vitro BioPharma Engages Senior Director of Sales and Marketing

Vitro BioPharma engages Senior Director of Sales and Marketing GOLDEN, CO/ACCESSWIRE/October 23,2018/Vitro Diagnostics, Inc. (OTC PINK: VODG), dba Vitro BioPharma today announced the engagement of a senior Sales and Marketing Director. The company has engaged Keith V....

Our Products and Services

We are distinct from our competitors by a unique mix of proprietary formulations, technical know-how and patent-pending technology yielding substantial competitive advantages. Through our extensive commercial manufacturing experience, we are capable of highly efficient stem cell production yielding high margins for our clinical trial stem cell therapies.  We also manufacture our own MSC-Gro media for all cellular manufacturing yielding further cost savings and additional manufacturing efficiencies.

With rigorous control of all cell culture parameters our clinical grade stem cells are not only economical but exhibit potency advantages as well that optimize superior clinical performance. In addition to Best in Class stem cell products for transplantation, we have also developed stem cell activation products targeting adult stem cells.  This allows us to follow (or proceed) an adult stem cell transplant with further therapy to activate or differentiate stem cells to enhance and maximize the therapeutic benefit of a stem cell transplant.  Our CLIA-registered laboratory also provides biomarker profiling of the stem cells for the quantitation of stem cell status and measurement of therapeutic effects.

Cell Culture Media

We have developed several novel cell culture media formulations through over 25 years of research in this field.

Cell Lines

We provide human stem cell lines for use in research, drug discovery/development and pre-clinical studies.

Biomarker Profiling

Biomarker profiling plays an important role in drug discovery, diagnostics and molecular medicine.


Activate Stem Cells to Migrate and Produce New Stem Cells. Find out all the benefits  it has to offer here!

“We are testing almost 10 kind of mediums from different makers. The result is that your MSC-GroTM is most powerful candidate among them.”

Beike Biotech, Inc.

Providing high quality commercialized cell lines, media, stem cell products & stem cell technology

Providing applications in stem cell research, drug discovery and STEM CELL therapies

Customer Service (303)-999-2130 Ext. 1

4621 Technology Drive Golden, CO 80403

Technical Support (303)-999-2130 Ext. 2

Accounting (303)-999-2130 Ext. 3

Please click the image above to view our ISO 13485:2016.

Please click the image above to view our ISO 9001:2015 Certification.

Please click the image above to view our FDA registration.